Listar DBBM-Artículos, capítulos... por autor "067ffc2e-9d24-4d8c-a33b-b42bfcd3cb86"
Mostrando ítems 1-1 de 1
-
Thioredoxin Downregulation Enhances Sorafenib Effects in Hepatocarcinoma Cells
López-Grueso, María José; González, Raúl; Muntané Relat, Jordi; Bárcena Ruiz, José Antonio; Padilla, Alicia (MDPI, 2019)Sorafenib is the first-line recommended therapy for patients with advanced hepatocarcinoma (HCC) in de-differentiation stage (presenting epithelial–mesenchymal transition, EMT). We studied the role of the thioredoxin system ...